1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
Details for Australian Patent Application No. 2005210114 (hide)
International Classifications
Event Publications
31 August 2006 PCT application entered the National Phase
PCT publication WO2005/074922 Priority application(s): WO2005/074922
24 February 2011 Assignment before Grant
Pfizer Italia S.r.l. The application has been assigned to Nerviano Medical Sciences S.r.l.
14 July 2011 Application Accepted
Published as AU-B-2005210114
10 November 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005210117-Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
2005210106-Combined use of PRAME inhibitors and HDAC inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser